Advisor Group Holdings, Inc. Crispr Therapeutics Ag Transaction History

Advisor Group Holdings, Inc.

$39.8 Billion
Q4 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 45,474 shares of CRSP stock, worth $2.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,474

Previous 84,804 46.38%

Holding current value

$2.26 Million

Previous $3.98 Million 55.1%

% of portfolio

0.0%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$38.65 - $55.15 $1.52 Million - $2.17 Million	-39,330 Reduced 46.38%	45,474 $1.79 Million
Q3 2024 Nov 13, 2024	SELL	$44.62 - $62.75 $160,498 - $225,711	-3,597 Reduced 4.07%	84,804 $3.98 Million
Q2 2024 Aug 13, 2024	SELL	$51.17 - $68.18 $135,600 - $180,677	-2,650 Reduced 2.91%	88,401 $4.77 Million
Q1 2024 May 10, 2024	BUY	$60.67 - $89.12 $35,309 - $51,867	582 Added 0.64%	91,051 $6.21 Million
Q4 2023 Feb 12, 2024	SELL	$38.62 - $72.18 $504,068 - $942,093	-13,052 Reduced 12.61%	90,469 $5.66 Million
Q3 2023 Nov 13, 2023	BUY	$45.39 - $59.0 $830,637 - $1.08 Million	18,300 Added 21.47%	103,521 $4.7 Million
Q2 2023 Aug 21, 2023	SELL	$43.47 - $67.77 $479,387 - $747,367	-11,028 Reduced 11.46%	85,221 $4.78 Million
Q2 2023 Aug 10, 2023	BUY	$43.47 - $67.77 $487,689 - $760,311	11,219 Added 13.19%	96,249 $5.4 Million
Q1 2023 May 12, 2023	BUY	$41.0 - $56.12 $660,715 - $904,373	16,115 Added 23.38%	85,030 $3.85 Million
Q4 2022 Feb 10, 2023	BUY	$39.19 - $65.67 $700,168 - $1.17 Million	17,866 Added 35.0%	68,915 $2.8 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $7,270 - $9,969	119 Added 0.23%	51,049 $3.34 Million
Q2 2022 Aug 10, 2022	SELL	$43.23 - $73.83 $27,234 - $46,512	-630 Reduced 1.22%	50,930 $3.12 Million
Q1 2022 May 04, 2022	BUY	$53.19 - $79.24 $509,400 - $758,881	9,577 Added 22.81%	51,560 $3.07 Million
Q3 2021 Nov 05, 2021	BUY	$110.2 - $156.64 $773,604 - $1.1 Million	7,020 Added 20.08%	41,983 $4.7 Million
Q2 2021 Aug 02, 2021	BUY	$100.84 - $161.89 $496,132 - $796,498	4,920 Added 16.38%	34,963 $5.65 Million
Q1 2021 May 13, 2021	BUY	$110.72 - $210.04 $1.38 Million - $2.62 Million	12,476 Added 71.02%	30,043 $3.65 Million
Q4 2020 Feb 10, 2021	SELL	$79.67 - $173.23 $326,886 - $710,762	-4,103 Reduced 18.93%	17,567 $2.69 Million
Q3 2020 Nov 12, 2020	BUY	$78.5 - $100.64 $178,273 - $228,553	2,271 Added 11.71%	21,670 $1.81 Million
Q2 2020 Aug 14, 2020	BUY	$38.5 - $76.05 $8,547 - $16,883	222 Added 1.16%	19,399 $1.43 Million
Q1 2020 May 18, 2020	BUY	$33.68 - $62.53 $645,881 - $1.2 Million	19,177 New	19,177 $821,000

Others Institutions Holding CRSP

# of Institutions

494

Shares Held

64.3M

Call Options Held

1.68M

Put Options Held

1.95M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.88B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Crispr Therapeutics Ag Transaction History